EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa

Elisa Molinelli, Helena Gioacchini, Claudia Sapigni, Federico Diotallevi iD, Valerio Brisigotti, Giulio Rizzetto iD, Annamaria Offidani, Oriana Simonetti

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elisa Molinelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60126 Ancona, Italy. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is an immune-mediated inflammatory disorder characterized by deep-seated nodules, abscesses, sinus tracts and scars localized in the intertriginous areas. It is accompanied by pain, malodourous secretion and a dramatically decreased quality of life. Although the pathogenesis has not been entirely elucidated, the primary event is follicular hyperkeratosis of the pilosebaceous apocrine unit. Since the registration of the tumor necrosis factor-alpha inhibitor Adalimumab in 2015, several cytokines have been implicated in the pathomechanism of HS and the research of novel therapeutic targets has been intensified. We provide an update on the inflammatory cytokines with a central role in HS pathogenesis and the most promising target molecules of future HS management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansQuality of LifeAdalimumabSkinCytokines

Stichwörter der Autor:innen

adalimumabbiologicshidradenitis suppurativainfliximabsecukinumabtherapy

Substanzen

AdalimumabCytokines

Autor:innen und Institutionen

  • Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60126 Ancona, Italy.

ORCID-Profile: Federico Diotallevi, Giulio Rizzetto

Zitieren

APA

Molinelli, E., Gioacchini, H., Sapigni, C., Diotallevi, F., Brisigotti, V., Rizzetto, G., Offidani, A., & Simonetti, O. (2023). New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098428

Vancouver

Molinelli E, Gioacchini H, Sapigni C, Diotallevi F, Brisigotti V, Rizzetto G, et al. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098428

BibTeX
@article{Molinelli2023,
  author = {Molinelli, Elisa and Gioacchini, Helena and Sapigni, Claudia and Diotallevi, Federico and Brisigotti, Valerio and Rizzetto, Giulio and Offidani, Annamaria and Simonetti, Oriana},
  title = {New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098428}
}
Kostenlos starten →